Lundbeck Germany News and Activities

Lundbeck Germany is owned by Lundbeck.

Lundbeck is a company listed under the stock ticker HLUYY (DK).

Lundbeck has a direct presence in 7 countries.

Lundbeck has 6 subsidiaries including Lundbeck Australia, Lundbeck Canada and Lundbeck Germany.

Acquisition, funding and merger involving Lundbeck.

• Lundbeck has announced the acquisition of Longboard Pharmaceuticals  (posted on October 17 2024).

View the org chart displaying its 3 main executives

Most searched biographies at Lundbeck Germany

• Andrea Jung, Managing Director
• Kristina Schulte-Herweling, Commercial Director
• Med Lochschmidt, Group Product Manage

Popular executive movements at Lundbeck

• Lluís Pujadas Mestres has joined the company as Medical and Regulatory Director, Iberia  (posted on May 15 2026).

Create your alert
to follow the executive moves at Lundbeck Germany.

Lundbeck has 1,913 competitors including Sanofi (France), Eli Lilly (United States (USA)) and Moderna (United States (USA)).

Popular M&A news in Pharmaceuticals

• Contraline has just announced a $93 Million fundraising (posted on June 3 2026).
• Hims & Hers has acquired Eucalyptus (posted on June 2 2026).
• Apotex has filed its IPO. Its stock ticker will be TSX. (posted on June 2 2026).

Popular contacts in Pharmaceuticals

• Joaquin Duato - Chief Executive Officer and Chairman of the Board at Johnson & Johnson
• Richard Saynor - Chief Executive Officer at Sandoz
• Robert Ford - Chief Executive Officer and Chairman of the Board at Abbott

Learn more about the Pharmaceuticals industry

Press releases by Lundbeck Germany

Social media about Lundbeck Germany

• Lundbeck Germany on Wikipedia, Google News & Yahoo Finance
• Lundbeck Germany on LinkedIn, X (Twitter) & YouTube